Skip to main content

Table 5 Diagnostic scoring of IBS

From: Evaluation of the diagnostic performance of estimated fecal calprotectin and serum intelectin-1 and C-reactive protein solo or in combination for differentiation between patients with query ulcerative colitis and irritable bowel syndrome

Data

Number (%)

Rome IV

Recurrent abdominal pain

291 (100%)

Change in frequency

177 (60.8%)

Change in form

152 (52.2%)

Number of criteria

2

253 (86.9%)

 > 2

38 (13.1%)

Bristol Stool Score

Constipation

42 (14.4%)

Diarrhea

63 (21.6%)

Mixed

49 (16.8%)

Unclassified

137 (47.2%)

IBS disease activity index

Items

Score = 0

Score = 1

Score = 2

Score = 3

Abdominal pain

0

85 (29.2%)

117 (40.2%)

89 (30.6%)

Diarrhea

228 (78.4%)

27 (9.3%)

19 (6.5%)

17 (5.8%)

Constipation

249 (85.6%)

17 (5.8%)

13 (4.5%)

12 (4.1%)

Nausea

144 (49.5%)

49 (16.8%)

57 (19.6%)

41 (14.1%)

Bloating

103 (35.4%)

73 (25.1%)

41 (14.1%)

74 (25.4%)

Anorexia

105 (36.1%)

81 (27.8%)

56 (19.2%)

49 (16.8%)

Patients’ distribution according to total score

 < 10

247 (84.9%)

 ≥ 10

44 (15.1%)